IQVIA MedTech’s Post

Understanding the impact of #GLP1 on your #MedTech business is of crucial importance - both to anticipate what's next and to answer questions from your investors. This is an area where IQVIA MedTech can help!

NEW INSIGHTS: GLP-1 and Impact on Medtech sector... through the lens of Real-World Evidence & Data! #medtech companies are already considering how best to articulate the continued value of their products – to audiences including #regulators, #physicians, #payers, and #analysts. A crucial step is to understand the company’s target patient populations through the lens of #glp1 use. Thanks Chris Ludwig and Michelle Edwards for sharing these insights. Francois Laflamme Joe Franco, MBA Chris Hankey Andrew Al Tork Sabrina S. Charles #medtech #medicaldevices #bariatricsurgery #cardiovascular #sleepapnea #diabetes #stroke #realworldevidence #patientoutcomes #clinicalpractice #surgicalprocedures #weareiqvia

GLP-1 drugs, that help with weight loss, have been on the market for many years, but recent trials are being designed with endpoints that have a direct impact on medical devices (ex: Dialysis, CPAP machines). But, what is the real risk for the MedTech companies? Learn more about it in this article from IQVIA #medtech #iqvia

The noise around GLP-1s and their potential impact on the MedTech sector is intensifying. In this new blog, IQVIA MedTech discusses the importance of having the right data and analytics in place to cut through the generalizations - allowing you to reveal the complete picture for your business. Read now. Authors: Chris Ludwig and Michelle Edwards https://bit.ly/3HIXkSV #GLP1 #MedTech

How are GLP-1s impacting your business? If you’re not clear, it’s time to cut through the noise with IQVIA MedTech, as our experts uncover the challenges and opportunities of GLP-1s – allowing you to plan with confidence for a successful MedTech future. Watch on-demand: https://lnkd.in/eiKuWdsJ #GLP1 Joanna Wills

Discover the latest trends reshaping central laboratory services across Europe and the US! Our latest article on SpendEdge explores technological advancements, regulatory changes, and innovative practices that are driving the future of laboratory services. Gain valuable insights to help your organization stay competitive and enhance service delivery in the healthcare sector. For further reading, click here: https://lnkd.in/gjWH7aKv #CentralLaboratoryServices #HealthcareTrends #LaboratoryInnovation #Europe #US #TechnologyAdvancements #RegulatoryChanges #ServiceDelivery

Clear data empowers clients to make impactful decisions. That’s why we're proud to publish our 8th annual Drug Trend Report. It's one of the many ways our transparent, pass-through model gives you the clearest view of our industry. Download the full report now: https://lnkd.in/gJEgFvwG #DrugTrendReport

From my colleague Chris Ludwig, the latest in GLP-1 considerations for MedTech industry; on the heels of recent data announcements and expanded indications for these therapies, it's important for stakeholders to take a measured approach to both proactive and reactive strategy and competitive intelligence here...

Our customers tell us #AsktheAnalyst is what they value most about their Citeline subscription for bespoke answers to their specific business questions. Get in touch to find out more here: https://ow.ly/8ZN450Q7iIT #asktheanalyst #citeline

The growing number of options and types of available data in the #pharma industry calls for a greater understanding of the data and how to best leverage it. For insights into building an inclusive #dataaggregation strategy, read our latest fact sheet: https://bit.ly/3NqGiMt